California NanoSystems Institute
CNSI
Text Size: A A A A

January 29, 2014


UCLA Managing Invention Seminar featuring Gregory C. Simon

Abstract

Our American democracy was based on the idea that wealth was a proxy for wisdom. It took the Civil War, the suffragette movement and the Vietnam War to "democratize democracy" by expanding the franchise to non-propertied men, non-white citizens, women and younger people. Our economic system mirrored the approach of treating wealth as a proxy for wisdom. Plantation owners gave way to oil titans, railroad barons, communication monopolies, big banks and the venture capital industry, each of which was aided by governmental policies that treated wealth as a proxy for wisdom. Even as recently as 1974, the SEC limited investments in private offerings to wealthy Americans on the theory that only the wealthy were wise enough to risk their money in private ventures.

With the JOBS Act,our economic system has finally caught up with our Democracy and recognized that wealth is not a proxy for wisdom. All of us now have the chance to choose a future directly instead of delegating that choice to a small group of wealthy individuals.

About the Speaker

The journal Nature Medicine named Greg Simon one of “Ten People to Watch" in health care policy, noting that he was among "a handful of influential people who quietly keep the wheels of biomedical science turning." Greg is currently the CEO of Poliwogg Healthcare Investments. He has a reputation as a visionary strategist, dynamic public speaker and writer, and as a knowledgeable analyst of emerging trends in healthcare, information technology, drug research and development, and patient advocacy. Previously, Greg has held senior positions in both houses of Congress and the White House and has been a senior strategy consultant to a number of international technology CEOs.

Most recently Mr. Simon was Senior Vice President for Patient Engagement at Pfizer, Inc. Prior to joining Pfizer, Mr. Simon was the founding President of FasterCures/The Center for Accelerating Medical Solutions, a cornerstone of the Milken Institute. Before this, Greg was CEO of Simon Strategies and provided strategic advice to CEOs of major international firms such as Sony, Cisco, Netscape, Motorola, Sega and AOL. Mr. Simon was Chief Domestic Policy Advisor to Vice President Al Gore from 1993 to 1997. He represented the Vice President on the National Economic Council, helped negotiate the U.S.-Russia agreement on the International Space Station and oversaw a number of key initiatives, including programs at the NIH, the NCI, the FDA and the Human Genome Project.


April 02, 2013

Henry Samueli, Ph.D., Co-founder, Senior Vice President, and Chief Technology Officer, Broadcom Corporation
IMED / Managing Invention - Henry Samueli, Ph.D., Broadcom Corporation
Biography:

Dr. Henry Samueli is a Co-Founder of Broadcom Corporation and serves as Chairman of the Board and Chief Technical Officer (CTO). In this role, he is responsible for driving the vision of Broadcom's research and development activities as well as helping to lead corporate-wide engineering development strategies.

Dr. Samueli has more than 30 years of experience in the fields of communications systems engineering and digital signal processing. Since co-founding Broadcom, he has also served as Chairman and Co-Chairman of the Board and Vice President of Research and Development.

Since 1985, Dr. Samueli has been a professor in the Electrical Engineering Department at the University of California, Los Angeles (UCLA), where he has supervised advanced research programs in broadband communications circuits and digital signal processing, and he has published more than 100 technical papers in these areas. He has been on a leave of absence from UCLA since 1995. Dr. Samueli is also a Distinguished Adjunct Professor in the Electrical Engineering and Computer Science Department at the University of California, Irvine. Dr. Samueli was the Chief Scientist and one of the founders of PairGain Technologies, Inc., a telecommunications equipment manufacturer in the digital subscriber line (DSL) industry, and he consulted for PairGain from 1988 to 1994. From 1980 until 1985, Dr. Samueli served in a variety of engineering management positions in the Electronics and Technology Division of TRW, Inc., where he was responsible for the development of military broadband communications systems.

Dr. Samueli received a B.S., M.S. and Ph.D. in Electrical Engineering from UCLA. He is a named inventor in 70 U.S. patents. In June 2012 Dr. Samueli was awarded the Marconi Society Prize and Fellowship and in December 2011 the Global Semiconductor Alliance (GSA) named him the winner of the Dr. Morris Chang Exemplary Leadership Award. He is a Fellow of the Institute of Electrical and Electronics Engineers (IEEE), a Fellow of the American Academy of Arts and Sciences (AAAS) and a Member of the National Academy of Engineering (NAE).

For more information about the seminar, please visit IMED

September 24, 2012

Albert Cha, Managing Partner, Vivo Ventures
Ira Ehrenpreis, General Partner, Technology Partners
CNSI Special Seminar: A Venture Capital Perspective on Market Opportunities in Life Sciences and Cleantech




Talk Title: A Venture Capital Perspective on Market Opportunities in Life Sciences and Cleantech
Where: CNSI Auditorium
When: Monday, September 24th at 4:00pm

SPACE IS LIMITED

Please RSVP to cnsievents@cnsi.ucla.edu

Event Flyer

About the Speakers:
Albert Cha, M.D., Ph.D. is a Managing Partner at Vivo Ventures who invests in private and public biopharmaceutical and medical device companies with over $1 billion under management. Albert draws on his scientific, medical, and operating experience when working with his portfolio companies. He was an early investor in Aspreva Pharmaceuticals (NASDAQ: ASPV, acquired by Galenica), Bioform Medical (BFRM, acquired by Merz), Vicept Therapeutics (acquired by Allergan), and Biodel (BIOD). Other investments include Acura Pharmaceuticals (ACUR), AMAG Pharmaceuticals (AMAG), and Avanir Pharmaceuticals (AVNR). He currently serves on the board of several private biopharmaceutical and medical device companies.

Mr. Ira Ehrenpreis, is General Partner at Technology Partners a venture capital firm investing in Cleantech and Life Sciences with approximately $700 million under management. Mr. Ehrenpreis has been with Technology Partners since 1996 where he leads the firm's Cleantech investment practice, investing in Energy Technology, Water Technology, and Advanced Materials opportunities. He serves on the Board of the National Venture Capital Association (NVCA) and on the Board of the Western Association of Venture Capitalists (WAVC). He is also the Co-Chairman of both the VCNetwork and the YVCA, two non-profit organizations comprising more than 1,000 venture capitalists. He currently serves on the board of Tesla Motors and several other Cleantech companies.

Contact:
David Ghatan, dghatan@cnsi.ucla.edu

June 28, 2012

Muthiah Manoharan,Ph.D.
Senior Vice President, Drug Discovery
Alnylam Pharmaceuticals, Inc.

Making Drugs Out of siRNA
Dr. Muthiah Manoharan,
Senior Vice President, Drug Discovery
Alnylam Pharmaceuticals, Inc.

SPACE IS LIMITED
Please RSVP to cnsievents@cnsi.ucla.edu CNSI Presentation Space - 5th Floor

Event Flyer

Speaker Bio:
Dr. Manoharan was the former Executive Director of Medicinal Chemistry at Isis Pharmaceuticals, Inc., a leading biotechnology company focused on nucleic acid-based therapeutics where he had a 12-year tenure. With a distinguished career as a world-leading nucleic acid and bioconjugate chemist, Dr. Manoharan is an author on over 130 publications and over 200 abstracts, as well as the inventor on over 115 issued U.S. patents. Prior to Isis Pharmaceuticals, he earned his Ph.D. in chemistry at the University of North Carolina-Chapel Hill and conducted post-doctoral work at Yale University and the University of Maryland.

About the Series:
The California NanoSystems Institute (CNSI), the Institute for Molecular Medicine (IMED), and UCLA Anderson School of Mangement have teamed up to create a new educational seminar series at UCLA called Managing Invention. The series is designed to inspire faculty and student researchers interested in turning their discoveries into breakthrough technologies and start-up companies. Stimulate the inventor in you!

Contact:
David Ghatan, dghatan@cnsi.ucla.edu

June 06, 2012

Sizhao (Zao) Yang
Co-creator Farmville
Hooked on Gaming: Applications for Education, Scientific Knowledge and Marketing
Sizhao (Zao) Yang, Co-creator Farmville

Event Flyer

Speaker Bio:

Sizhao “Zao” Yang is currently the COO/co-founder at BetterWorks, Inc., a perks platform for small and medium sized businesses. Previously, he co-created Farmville, and was the CEO/co-founder of MyMiniLife, Inc. (sold to Zynga Game Networks, Inc.). After the acquisition, MyMiniLife became the common technology platform at Zynga and powers 150M monthly users including games like Cityville, Farmville, and Frontierville. He also designed the Farmville iPhone application (top iPhone app), and worked on corporate development deals including Microsoft, Yahoo, Zynga Japan, and Zynga corporate strategy. He is also an active investor with stakes in companies like Hipmunk, GroupMe, Facebook, Zynga (acquisition stock), and SV Angels. He received a B.S. in computer science at University of Illinois at Urbana Champaign.


May 29, 2012

John Stevenson, Director of Kung Fu Panda
Monsters, Muppets and Movies: Finding Passion in Science and Art
John Stevenson, Director of Kung Fu Panda

Event Flyer

Speaker Bio:

John Stevenson began his career as an artist and illustrator on a wide variety of projects including the Children's Museum of Bogota, Colombia. His entry into the entertainment business came via Jim Henson Productions, for which he provided character design, storyboarding and even background puppetry on the much-loved "Muppet Show." He later contributed storyboards and helped develop the visuals for many of Henson-related live action features, including "The Great Muppet Caper" (1981), "The Dark Crystal" (1982) and "Little Shop of Horrors" (1986).

From 1989 to 1991, Stevenson was art director and character designer for "The Dreamstone" (ITV, 1990-95), a popular animated fantasy series in the UK. After that, he served as staff designer and director for Colossal Pictures from 1991 to 1995; among the projects he oversaw at the company was the weekly animated series "Back to the Future" (CBS, 1991-92) and advertising spots for Parker Bros. and Little Caesars, among many others. As the decade progresses, Stevenson began to add feature animation work to his steady diet of TV programming. As a freelance storyboard artist, he created the opening title sequence for "George of the Jungle" (1997) and worked on "Antz" (1998) and "Toy Story 2" (1999), among numerous other projects. He was also an independent consultant for several major networks as well as to Walt Disney Productions, and collaborated with director Henry Selick on "James and the Giant Peach" (1996) as both storyboard artist and puppeteer.

In the late '90s, Stevenson joined DreamWorks as Head of Story for their most successful animated projects, including "Shrek" (2001), "Shrek 2" "(2004) and "Madagascar" (2005). He also provided storyboards for several less-known DreamWorks animated features, including "Spirit: Stallion of the Cimarron" (2002) and "Sinbad: Legend of the Seven Seas" (2003), and provided story art and consultation for Aardman Animations' uncompleted claymation feature "The Tortoise and the Hare." Stevenson, who made his directorial debut on the offbeat CBS animated series "The Twisted Tales of Felix the Cat" (1995), later helmed several episodes of DreamWorks' costly and heavily promoted primetime animated program, "Father of the Pride."

While working on "Pride," Stevenson began working on "Kung Fu Panda," a feature project for DreamWorks that had been gestating since 1993. After partnering with Academy Award-nominated animator Mark Osbourne in the director's chair, Stevenson helped to develop the film's unique mix of comedy, martial arts action and authentic Chinese culture; he also tempered the film's original thrust, which was more of a parody than a straight-ahead comedy. "Kung Fu Panda" opened to the largest opening day box office gross for a non-sequel in DreamWorks' history, and earned a total of 11 Annie Awards, including Best Picture. In 2009, Stevenson added Best Picture nods from both the Academy Awards and Golden Globes to his growing list of accolades. That same year, Stevenson made his jump to live action direction when producer Joel Silver selected him to direct a new version of the long-running animated and toy favorite "Masters of the Universe" for movie screens.

About the Series: The California NanoSystems Institute (CNSI) and the Institute for Molecular Medicine (IMED) have teamed up to create a new educational seminar series at UCLA called Managing Invention. The series is designed to inspire faculty and student researchers interested in turning their discoveries into breakthrough technologies and start-up companies. Stimulate the inventor in you!

Contact:
Lee Goodglick, Ph.D., lgoodglick@mednet.ucla.edu
or
David Ghatan, dghatan@cnsi.ucla.edu

May 07, 2012

Richard Riordan, Former Mayor of the City of Los Angeles, Chairman of the Riordan Foundation
Building Business Success
bio:Richard J. Riordan currently serves as the Chairman of the Riordan Foundation. In addition, to serving as board member of the Alliance for College Ready Public Schools, a successful charter management organization that operates thirteen middle and high schools in Los Angeles. He previously served as Secretary for Education, under Governor Schwarzenegger, where he advised the governor on education policy.

Riordan's appointment as Secretary for Education was a natural extension of his civic activism that began well before his entry to public service. In 1981, Riordan created the charitable foundation that bears his name with one goal in mind: to teach children how to read and write. Through its signature" Rx for Reading" program, The Riordan Foundation has distributed some 25,520 computers to 2,140 schools in 40 states and enabled the purchase of over 172,000 books for elementary classroom libraries.

Read more about The Riordan Foundation

Flyer

About the series
The Managing Invention Seminar Series is co-sponsored by the California NanoSystems Institute (CNSI) and the Institute for Molecular Medicine (IMED). These seminars will focus on the actual logistics of how to manage and build on discoveries here on campus. The goals of this series are to connect the UCLA community, bring to light available resources, and communicate the stories of successful discoveries.

For additional information, please contact:
Lee Goodglick, Ph.D.,lgoodglick@mednet.ucla.edu
David Ghatan,dghatan@cnsi.ucla.edu



March 06, 2012

Vinton Cerf
VP and Chief Internet Evangelist, Google
Web 3.0 and Beyond: Implications for Science, Medicine, and the Arts

FEATURED SPEAKER:
Vinton G. Cerf, Vice President and Chief Internet Evangelist, Google

Vinton G. Cerf has served as vice president and chief Internet evangelist for Google since October 2005. In this role, he is responsible for identifying new enabling technologies to support the development of advanced, Internet-based products and services from Google. He is also an active public face for Google in the Internet world.

Cerf is the former senior vice president of Technology Strategy for MCI. In this role, Cerf was responsible for helping to guide corporate strategy development from the technical perspective. Previously, Cerf served as MCI's senior vice president of Architecture and Technology, leading a team of architects and engineers to design advanced networking frameworks including Internet-based solutions for delivering a combination of data, information, voice and video services for business and consumer use.

Widely known as one of the "Fathers of the Internet," Cerf is the co-designer of the TCP/IP protocols and the architecture of the Internet. In December 1997, President Clinton presented the U.S. National Medal of Technology to Cerf and his colleague, Robert E. Kahn, for founding and developing the Internet. Kahn and Cerf were named the recipients of the ACM Alan M. Turing award in 2004 for their work on the Internet protocols. The Turing award is sometimes called the "Nobel Prize of Computer Science." In November 2005, President George Bush awarded Cerf and Kahn the Presidential Medal of Freedom for their work. The medal is the highest civilian award given by the United States to its citizens. In April 2008, Cerf and Kahn received the prestigious Japan Prize.

Prior to rejoining MCI in 1994, Cerf was vice president of the Corporation for National Research Initiatives (CNRI). As vice president of MCI Digital Information Services from 1982-1986, he led the engineering of MCI Mail, the first commercial email service to be connected to the Internet. During his tenure from 1976-1982 with the U.S. Department of Defense's Advanced Research Projects Agency (DARPA), Cerf played a key role leading the development of Internet and Internet-related packet data and security technologies.

Cerf holds a Bachelor of Science degree in Mathematics from Stanford University and Master of Science and Ph.D. degrees in Computer Science from UCLA. He also holds an honorary Doctorate degrees from the Swiss Federal Institute of Technology (ETH), Zurich, and several other prestigious institutions.

Event Flyer

ABOUT THE SERIES:

The Managing Invention Seminar Series is co-sponsored by the California NanoSystems Institute (CNSI) and the Institute for Molecular Medicine (IMED). These seminars will focus on the actual logistics of how to manage and build on discoveries here on campus. The goals of this series are to connect the UCLA community, bring to light available resources, and communicate the stories of successful discoveries.

For additional information, please contact:
Lee Goodglick, Ph.D.,lgoodglick@mednet.ucla.edu
David Ghatan,dghatan@cnsi.ucla.edu



February 06, 2012

Albert Cha, M.D
Managing Partner
Vivo Ventures
Identifying Revolutionary Ideas
Albert Cha, M.D., Ph.D. is a Managing Partner who invests in private and public biopharmaceutical and medical device companies. Albert draws on his scientific, medical, and operating experience when working with his portfolio companies. He was an early investor in Aspreva Pharmaceuticals, Bioform Medical, Vicept Therapeutics, and Biodel. Other investments include Acura Pharmaceuticals, AMAG Pharmaceuticals, and Avanir Pharmaceuticals. He currently serves on the board of several private biopharmaceutical and medical device companies. Albert has also served as co-founder of several portfolio companies. Prior to joining Vivo, Albert worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. Albert received his B.S. and M.S. in Electrical Engineering from Stanford University. He subsequently completed the Medical Scientist Training Program at UCLA School of Medicine, where he received his M.D. and Ph.D. in Neuroscience. During his studies, he was elected to Alpha Omega Alpha and won the prestigious Outstanding Graduate Student Award. His research in molecular biophysics has been published in highly respected journals such as Nature and Neuron.

Flyer

For additional information, please contact: Lee Goodglick, Ph.D., lgoodglick@mednet.ucla.edu or David Ghatan, dghatan@cnsi.ucla.edu

January 09, 2012

Carla Mann Woods
V.P. of Strategic Planning and Program
Development at the Alfred E. Mann
Foundation for Biomedical Engineering

Ventures in Biotechnology
Carla Mann Woods, Vice President of Strategic Planning and Program Development at the Alfred E. Mann Foundation for Biomedical Engineering, is a member of the Alfred Mann Institute (AMI)-USC and the AMI-Purdue Board of Directors and has been appointed to the Advisory Board of the Center for Global Innovation at the USC Marshall School of Business. She is also a member of the Board of Governors for The Fulfillment Fund, and formerly on the Board of the National Pain Foundation. A USC graduate in Business Administration and Entrepreneurship, Carla began her career at Pacesetter Systems in Business Development and Marketing to research and plan new technology applications and product needs for pacemakers. Later, she joined Advanced Bionics, a cochlear implant company acquired by Boston Scientific. During her tenure at Advanced Bionics/Boston Scientific, she was involved in the business development, product development, and marketing for the BION® microstimulator and the Precision Spinal Cord Stimulator and was the Vice President of Marketing for the Auditory Division. For these products she holds over 40 U.S. patents. In 2007, she became the Vice President of Program Development and Strategic Planning for the Alfred Mann Foundation for Biomedical Engineering to establish the model for creating and operating Alfred Mann Institutes (AMI) at universities.

Flyer

For additional information, please contact: Lee Goodglick, Ph.D., lgoodglick@mednet.ucla.edu or David Ghatan, dghatan@cnsi.ucla.edu


December 05, 2011



Streaming Video
Establishing Intellectual Property

Featured Speakers:
Emily Loughran & Earl Weinstein
UCLA’s Office of Intellectual Property
& Industry Sponsored Research

Topics Covered:
  • Why protect your intellectual property
  • How to protect your intellectual property
  • Licensing your discovery
  • Starting a start-up
  • Resources at UCLA


About The Series:
The CNSI and the IMED Seminar Series are teaming up to create a new educational seminar series that will be held once a month - called "Managing Invention". These seminars will focus on the actual logistics of how to manage and build on discoveries here on campus. The goals of this series are to connect the UCLA community, bring to light available resources, and communicate the stories of successful discoveries.

View Flyer

For additional information, please contact:
Lee Goodglick, Ph.D.,lgoodglick@mednet.ucla.edu
David Ghatan,dghatan@cnsi.ucla.edu

April 20, 2011


Navigating the FDA Process
  • Example case studies
  • High level road map of the FDA process
  • Common mistakes made by early stage companies
  • Critical milestones for early stage companies
Panelists:
Evan Siegel - President & CEO of Ground Zero Pharmaceuticals Inc.
Richard Phillips - Regulatory Consultant for PPD
Gretchen Jimenez - Principal Consultant and Co-Founder of Atheln, Inc.

Panelist Bios

Thirty-Thirty Incubator Panel Series
The California NanoSystems Institute has organized a series of panel discussions to address business development and spin-out issues facing the incubator companies and entrepreneurial faculty / students. Each event will feature a thirty minute panel discussion, followed by thirty minutes of questions from the audience. To guide discussions, the Thirty-Thirty series is geared towards start-ups at the UCLA / CNSI Technology Incubator.

March 23, 2011


Venture Capital and University Based Start-Ups
  • What are VC's looking for to invest in?
  • What do VC's NOT invest in?
  • Who should want venture capital?
  • How do you build your company to attract venture capital?
  • What is the current status of the overall VC industry?
  • Regional differences in venture capital between northern and southern CA?
Panelists:
Gilman Louie - Partner of Alsop Louie Partners
Maneesh Goyal - Principal of Miramar Venture Partners
Jeffrey Lee - Associate at Mission Ventures

Moderator:
Bryce Benjamin - CEO in Residence for the Lloyd Greif Center for Entrepreneurial Studies at USC Marshall School of Business

Panelist & Moderator Bios  Video

Thirty-Thirty Incubator Panel Series
The California NanoSystems Institute has organized a series of panel discussions to address business development and spin-out issues facing the incubator companies and entrepreneurial faculty / students. Each event will feature a thirty minute panel discussion, followed by thirty minutes of questions from the audience. To guide discussions, the Thirty-Thirty series is geared towards start-ups at the UCLA / CNSI Technology Incubator.

February 23, 2011


Early Stage Founder Positioning
  • How UCLA spins out startups
  • Aspects of founder positioning (legal and accounting)
  • Common mistakes made by founders of early stage companies
Panelists:
Thomas J. Speiss III - Partner at Lewis, Brisbois, Bisgaard & Smith LLP
Nir Shtolzberg - Senior Manager at Ernst & Young LLP
Earl Weinstein - Assistant Director, License and Business Development for the Office of Intellectual Property & Industry Sponsored Research, UCLA

Panelist Bios  Video

Thirty-Thirty Incubator Panel Series
The California NanoSystems Institute has organized a series of panel discussions to address business development and spin-out issues facing the incubator companies and entrepreneurial faculty / students. Each event will feature a thirty minute panel discussion, followed by thirty minutes of questions from the audience. To guide discussions, the Thirty-Thirty series is geared towards start-ups at the UCLA / CNSI Technology Incubator.

February 07, 2011




Assessing Business Feasibility
  • Common pitfalls of entrepreneurs
  • Positioning your startup - dos and don'ts
  • Importance of market analysis and business plan for startups
Panelists:
Anurag Bist - Founder and CEO of Moxair, and Ashmar
Alfred E. Osborne - Senior Associate Dean of UCLA Anderson School of Management
Stephen P. Rothman - Founder and Partner of Rothman & Stulberg, LLP

Panelist Bios  Video

Thirty-Thirty Incubator Panel Series
The California NanoSystems Institute has organized a series of panel discussions to address business development and spin-out issues facing the incubator companies and entrepreneurial faculty / students. Each event will feature a thirty minute panel discussion, followed by thirty minutes of questions from the audience. To guide discussions, the Thirty-Thirty series is geared towards start-ups at the UCLA / CNSI Technology Incubator.

January 26, 2011




Building a Sturdy Foundation - Startup Corporate Structure
  • Common pitfalls of entrepreneurs/startups
  • Tax implications LLC. Vs Inc.
  • VCs perspective on startup corporate structure
  • Practical issues from the entrepreneur's perspective
Panelists:
Scott Alderton - Founder and Partner of Stubbs Alderton & Markiles LLP
Christian Jester - Partner at PricewaterhouseCoopers LLP
Bryce Benjamin - CEO in Residence for the Lloyd Greif Center for Entrepreneurial Studies at USC Marshall School of Business

Panelist Bios  Video

Thirty-Thirty Incubator Panel Series
The California NanoSystems Institute has organized a series of panel discussions to address business development and spin-out issues facing the incubator companies and entrepreneurial faculty / students. Each event will feature a thirty minute panel discussion, followed by thirty minutes of questions from the audience. To guide discussions, the Thirty-Thirty series is geared towards start-ups at the UCLA / CNSI Technology Incubator.

January 12, 2011




Protect Your Intellectual Property
  • Reasons to pursue patenting IP
  • Common pitfalls of entrepreneurs when patenting IP
  • Patentability of IP
  • Patenting Process at UCLA
Panelists:
Kevin D. DeBre - Partner at Stubbs Alderton & Markiles LLP
Zhaoyang Li (Paul) - Partner at Squire Sanders
Emily W. Loughran - Director of Licensing at UCLA

Panelist Bios  Video

Thirty-Thirty Incubator Panel Series
The California NanoSystems Institute has organized a series of panel discussions to address business development and spin-out issues facing the incubator companies and entrepreneurial faculty / students. Each event will feature a thirty minute panel discussion, followed by thirty minutes of questions from the audience. To guide discussions, the Thirty-Thirty series is geared towards start-ups at the UCLA / CNSI Technology Incubator.

July 30, 2009

Speaker: Margaret Chock, PhD, CMC (Certified Management Consultant)
M. I. B. Chock, LLC
Information Technology for Startups
Information Technology is rarely on the minds of entrepreneurs, who have to focus on their product or service, its production, marketing, funding, staffing, and facilities, with little time for attention to anything else. However, computers are needed just to be in business and stay competitive. Their judicious use can provide significant efficiencies for even the smallest organization. On the other hand, lack of attention to IT-related risks can result in loss of data, loss of intellectual property, regulatory missteps, and possible consequent loss of the company altogether. Margaret Chock, a certified management consultant, will provide a brief overview of some of the technologies that may be useful in a startup company, describe the risks in their mismanagement, and suggest a roadmap for implementing basic information technology management procedures to keep costs in line with limited funding.

Start-ups need to be IT-savvy to:

Protect intellectual property
  • IP is the basis of the start-up company
  • Capture information to safeguard ideas
  • Backup critical data, and secure against theft
Utilize web technology
  • Manage the new company's face to the outside world
  • Attract potential customers and investors
IT Costs
  • Set up can be a significant investment
  • Initial equipment costs are only the tip of the iceberg
  • Maintenance and forced upgrades can be costly
Margaret Chock, PhD, CMC (Certified Management Consultant), has been Principal of M. I. B. Chock, LLC and its predecessors for 19 years. She has also held research, management, and technical positions in biotech, consulting, and aerospace companies.

Dr. Chock has BA degrees in Mathematics and Anthropology from University of California, Santa Barbara, and an MS and PhD. in Computer Science from UCLA. She is certified as a Management Consultant by the Institute of Management Consultants.

She is an active participant in a number of professional and technical organizations, in order to stay abreast of the latest business and technical issues and to find technical specialists and other resources that may be useful to her clients:
  • Association for Computing Machinery (ACM)
  • Independent Computer Consultants Association (ICCA)
  • Institute of Electrical and Electronic Engineers (IEEE) -
    Consultants Network, Biomedical Society, and Computer Society
  • Institute of Management Consultants (IMC),
    immediate Past President, Southern California Chapter,
  • Southern California Biomedical Council
  • Recent member of the UCLA Engineering Alumni Board

June 25, 2009

Speaker: Earl Weinstein, Assistant Director, License and Business Development,
Office of Intellectual Property & Industry Sponsored Research, UCLA
Forming a Startup around a UCLA Invention: Resources, Guides and Tips
UCLA has a long history in transitioning breakthrough research discoveries to the commercial sector via startup companies. In this seminar, Earl Weinstein from the Office of Intellectual Property will discuss some of the key success factors for these startups and provide guidance on how to form a startup as well as an overview of resources for faculty entrepreneurs.
  • Opportunity Recognition- is your idea the basis of a startup?
  • The Mindset of Successful Faculty Entrepreneurs- first things first?
  • The VC Mindset- risk management & the time value of capital
  • Crafting an investor "pitch"- the essential pieces
  • Alternatives to VC Financing- angels, grants and the bootstrap
  • Doing a Startup at UCLA- the process, resources & how we can help
Dr. Weinstein is Assistant Director, License and Business Development for the Office of Intellectual Property & Industry Sponsored Research, UCLA. He joined the technology transfer group at UCLA from PureTech Ventures, a seed stage venture capital firm in Boston. At PureTech he spent four years sourcing, evaluating and managing investments in life sciences startups spun directly out of research institutions. He is now working with scientists and engineers at UCLA who are interested in starting companies to advance the development of their technologies as well as developing licensing deals around more mature technologies with existing technology companies.

Prior to joining PureTech Ventures, Dr. Weinstein completed a PhD at MIT working on computational and experimental analysis of a novel form of gene regulation that was published in Science and awarded the AAAS Newcomb-Cleveland Prize. He completed his undergraduate degree at University of Pennsylvania.


May 28, 2009

Emily W. Loughran, Office of Intellectual Property & Industry Sponsored Research
Licensing to Start Ups: A step by step review of the process
Featured Speaker Emily W. Loughran is the Director of Licensing for the Office of Intellectual Property at UCLA. Loughran has worked in tech transfer for 15 years, and has a BS from UC Berkeley and an MBA from USC.

She will be covering:

  • letters of intent
  • option agreements
  • license agreements

April 16, 2009

Cheryl Silverman & Casie Kelly
Office of Intellectual Property
University of California, Los Angeles
UCLA Technology Transfer Basics
Cheryl and Casie will review technology transfer (path to patenting) at UCLA and the role of inventors throughout the process. During this seminar, they will discuss how inventors disclose inventions to the UCLA Office of Intellectual Property, the patenting timeline, costs, decisions to pursue patenting and the relationship with legal. Intellectual Property (IP) ownership and basic relations with industry and collaborations such as confidential disclosure and material transfer agreements will also be discussed. Afterwards, Cheryl and Casie will be available for further discussions.

Casie Kelly is a Licensing Officer at UCLA's Office of Intellectual Property. Prior to joining the office 3 years ago, Casie completed her PhD in microbiology at Harvard and earned bachelors degrees at UCLA in Chemistry and Microbiology. Casie is also a Patent Agent.

Cheryl Silverman, Patent Prosecution Manager at UCLA, works with OIPA Case Managers and patent counsel to manage the patent prosecution process with the ultimate goal of protecting the Regents IP assets. With a background in liberal arts and over 15 years experience in technology transfer at UCLA, Cheryl brings a wealth of experience to the complex business of technology transfer.


March 24, 2009


UCLA on-campus Technology Incubator -- Launch Event and Conference
The California NanoSystems Institute and the Office of Intellectual Property and Industry Sponsored Research will hold a conference to introduce the UCLA on-campus Incubator at CNSI as a novel way to support faculty research and the commercialization of university research. The conference will bring together a unique mix of faculty entrepreneurs, and representatives from industry start-up companies and venture capital firms who will discuss the role of technology transfer and the importance of technology incubators and will give illuminating case histories.


Incubator Launch Video Stream

The UCLA Incubator is the first on-campus incubator with a built in education program. Workshops are planned in cooperation with the Anderson School of Management and the School of Law to provide start-ups with support in all areas of business development. UCLA supports economic development of the scientific findings which are generated with federal support.

Conference Participants include:

Leonard H. Rome - Welcome Remarks
CNSI Interim Director, Senior Associate Dean for Research, David Geffen School of Medicine

Kathryn Atchison - Incubator Program and Role of Technology Transfer
Vice Provost of Intellectual Property & Industry Relations

UCLA Chancellor Gene Block - Key Speaker

Industry/start-up representatives and panel of faculty entrepreneurs/VCs:
Jeff Green, CEO Nano H2O - keynote speaker
Wenyuan Shi, Founding Scientist and Chief Scientific Advisor, C3
Jim Kim, Senior Partner, CMEA Capital
John Miao, TomoSoft Technologies, LLC

ADDITIONAL BACKGROUND:
The UCLA On-campus Technology Incubator is an innovative resource designed to help accelerate the growth of entrepreneurial start-up companies and early stage research projects based on technologies developed by UCLA faculty. It represents the first on-campus technology incubator that includes a built in education program.

The UCLA on-campus Technology Incubator at CNSI will ultimately house 4-5 start-up companies which will use the space for early stage incubation purposes. Having developmental lab space on campus with close access to UCLA faculty researchers and lab facilities is highly desirable for such start up companies. In addition, workshops are planned in cooperation with the UCLA Office of Intellectual Property, the Anderson School of Management and the School of Law to provide start-ups with support in all areas of business development.

The CNSI's physical facilities offer eight core lab facilities with state-of-the-art imaging instrumentations and nanofabrication clean rooms. A new Incubation space is in development to provide a suite of "research incubation" laboratories for new, highly interactive, cross-disciplinary research projects. The space will include an integrated cluster of offices and conferencing facilities.

UCLA Newsroom

UCLA Today

February 26, 2009

Joseph R. Baker
Patent Attorney
Gavrilovich, Dodd, and Lindsey, LLP


Patents 101: record-keeping/notebooks and inventorship determination

Joseph R. Baker's practice focuses on patent, trademark, trade secret and copyright matters, concentrating on patent and trademark prosecution. Mr. Baker has over ten years experience preparing and prosecuting patents in a variety of technical areas. He has prepared and prosecuted U.S. and foreign patents in many technical areas, including biotechnology such as stem cells, gene therapy, vector systems, genomics, proteomics, antibodies, nano-biotechnology, and bioinformatics; pharmaceuticals such as small molecules, formulations, liposomal delivery systems; medical devices; and material sciences such as nanotechnology materials. He has also prepared and negotiated significant patent and technology transfer licenses, and has written numerous legal opinions for clients on product clearance, patent infringement, invalidity and enforceability.

Mr. Baker received a Bachelor's degree in General Biology from the University of California, a Master's of Science degree from San Diego State University in Cell & Molecular Biology and a J.D. from California Western School of Law. Mr. Baker is registered to practice in the State of California, in the state of Washington and before the U.S. Patent & Trademark Office. Mr. Baker has held positions at large general practice and intellectual property firms as well as positions at a small biotechnology start-up company and a large multinational biotechnology company. In addition to his legal practice, Mr. Baker is an adjunct professor of law at California Western School of Law and a lecturer through the University of California, San Diego Extension program.